Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Boring CC AU - Squires TS AU - Tong T TI - Cancer statistics JA - Cancer PY - 1991/// VL - 41 SP - 19 EP - ER - TY - GEN AU - Goluboff E AU - Olsson CA TI - Urologists on a tightrope: coping with a changing economy JA - J Urol PY - /// VL - SP - EP - ER - TY - JOUR AU - Viola MV AU - Fromowitz F AU - Oravez S AU - Deb S AU - Finkel G AU - Lundy J AU - Hand P AU - Thor A AU - Schlom J TI - Expression of ras oncogene p21 in prostate cancer JA - N Engl J Med PY - 1986/// VL - 314 SP - 133 EP - 137 ER - TY - JOUR AU - Thompson TC AU - Southgate J AU - Kitchener G AU - Land H TI - Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ JA - Cell PY - 1989/// VL - 56 SP - 917 EP - M3 - 10.1016/0092-8674(89)90625-9 N1 - 10.1016/0092-8674(89)90625-9 UR - http://dx.doi.org/10.1016/0092-8674(89)90625-9 ER - TY - JOUR AU - Zhau HE AU - Wan D AU - Chung LK AU - Wei L AU - Hsieh JT AU - Ro J AU - Chung LWK TI - Expression of the HER-2//neu proto-oncogene in human prostate cancer JA - J Urol PY - 1991/// VL - 145 SP - 348A EP - ER - TY - JOUR AU - Isaacs WB AU - Ewing CM AU - Epstein JI AU - Carter BS TI - Suppression of human prostate carcinoma cell growth by p53 in vitro and analysis of p53 mutations in vivo JA - J Urol PY - 1991/// VL - 145 SP - 349A EP - ER - TY - JOUR AU - Petros JA AU - Dowton SB AU - Catalona WJ TI - Investigation of retinoblastoma transcripts in primary prostatic adenocarcinoma JA - J Urol PY - 1991/// VL - 145 SP - 293A EP - ER - TY - JOUR AU - Yatani R AU - Chigusa K AU - Akazaki K AU - Stemmerman GN AU - Welsh RA AU - Correa P TI - Geographic pathology of latent prostatic carcinoma JA - Int J Cancer PY - 1982/// VL - 29 SP - 611 EP - 616 ER - TY - JOUR AU - Waterhouse J AU - Shanmugaratnam R AU - Muir C AU - Powell J TI - Cancer incidence in five continents JA - Cancer Incidence PY - 1982/// VL - 6 SP - EP - ER - TY - JOUR AU - Levine RL AU - Wilchinsky M TI - Adenocarcinoma of the prostate: a comparison of disease in blacks versus whites JA - J Urol PY - 1979/// VL - 121 SP - 761 EP - ER - TY - JOUR AU - Gittes RF TI - Carcinoma of the prostate JA - N Engl J Med PY - 1991/// VL - 324 SP - 236 EP - ER - TY - JOUR AU - Steinberg GD AU - Carter BS AU - Beaty TL AU - Childs B AU - Walsh PC TI - The familial aggregation of prostate cancer: a case control study JA - J Urol PY - 1990/// VL - 143 SP - 313A EP - ER - TY - JOUR AU - Carter BS AU - Steinberg GD AU - Beaty TH AU - Walsh PC TI - Evidence for mendelian inheritance in the pathogenesis of prostate cancer JA - J Urol PY - 1991/// VL - 145 SP - 213A EP - ER - TY - JOUR AU - Ragde H AU - Aldape HC AU - Bagley CM TI - Ultrasound guided prostate biopsy; Biopsy gun superior to aspiration JA - Urology PY - 1988/// VL - 32 SP - 503 EP - M3 - 10.1016/S0090-4295(98)90029-2 N1 - 10.1016/S0090-4295(98)90029-2 UR - http://dx.doi.org/10.1016/S0090-4295(98)90029-2 ER - TY - JOUR AU - Hodge K AU - McNeal JE AU - Terris MK AU - Stamey TA TI - Random systematic versus directed ultrasound guided transrectal biopsies of the prostate JA - J Urol PY - 1989/// VL - 141 SP - 71 EP - ER - TY - JOUR AU - Torp-Pederson ST AU - Lee F TI - Transrectal biopsy of the prostate guided by transrectal ultrasound JA - Urol Clin North Am PY - 1989/// VL - 16 SP - 703 EP - ER - TY - JOUR AU - Chodak GW AU - Keller P AU - Schoenberg HW TI - Assessment of screening for prostate cancer using digital rectal examination JA - J Urol PY - 1989/// VL - 141 SP - 1136 EP - ER - TY - JOUR AU - Wang MC AU - Valenzuela LA AU - Murphy GP AU - Chu TM TI - Purification of a human prostate specific antigen JA - Invest Urol PY - 1979/// VL - 17 SP - 159 EP - ER - TY - JOUR AU - Nadji M AU - Tabei SZ AU - Castro A AU - Chu TM AU - Murphy GP AU - Wang MC AU - Morales AR TI - Prostate-specific antigen: an immunohistologic marker for prostatic neoplasms JA - Cancer PY - 1981/// VL - 48 SP - 1229 EP - 1232 ER - TY - JOUR AU - Killian CS AU - Emrich LJ AU - Vargas FP AU - Yang N AU - Wang MC AU - Priore RL AU - Murphy GP AU - Chu TM TI - Relative reliability of five serially measured markers for prognosis of progression in prostate cancer JA - J Natl Cancer Inst PY - 1986/// VL - 76 SP - 179 EP - 185 ER - TY - JOUR AU - Stamey TA AU - Yang N AU - Hay AR AU - McNeal JE AU - Freiha FS AU - Redwine E TI - Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate JA - N Engl J Med PY - 1987/// VL - 317 SP - 909 EP - 916 ER - TY - JOUR AU - Hudson MA AU - Bahnson RR AU - Catalona WJ TI - Clinical use of prostate specific antigen in patients with prostate cancer JA - J Urol PY - 1989/// VL - 142 SP - 1011 EP - ER - TY - JOUR AU - Benson MC AU - Whang IS AU - Olsson CA AU - McMahon DJ AU - Cooner WH TI - The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum PSA JA - J Urol PY - 1992/// VL - 147 SP - 817 EP - 821 ER - TY - JOUR AU - Carter HB AU - Andros R AU - Metter EJ AU - Fozard JL AU - Chan DW AU - Walsh PC TI - Early detection of prostate cancer using serial PSA measurements JA - J Urol PY - 1991/// VL - 145 SP - 382A EP - ER - TY - JOUR AU - Catalona WJ AU - Smith DS AU - Ratliff TL AU - Dodds KM AU - Coplen DE AU - Yuan JJ AU - Petros JA AU - Andriole GL TI - Measurement of prostate-specific antigen in serum as a screening test for prostate cancer JA - N Engl J Med PY - 1991/// VL - 324 SP - 1156 EP - 1161 ER - TY - JOUR AU - Lange PH AU - Brawer MK TI - Serum prostate-specific antigen; its use in diagnosis and management of prostate cancer JA - Urology PY - 1989/// VL - 33 SP - 13 EP - ER - TY - JOUR AU - Cooner WH AU - Mosley BR AU - Rutherford CL Jr AU - Beard JH AU - Pond HS AU - Bass RB Jr AU - Terry WJ TI - Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer JA - J Urol PY - 1988/// VL - 139 SP - 758 EP - 761 ER - TY - JOUR AU - Lee F AU - Littrup PJ AU - Torp-Pedersen ST AU - Mettlin C AU - McHugh TA AU - Gray JM AU - Kumasaka GH AU - McLeary RD TI - Prostate cancer: comparison of transrectal US and digital rectal examination for screening JA - Radiology PY - 1988/// VL - 168 SP - 389 EP - 394 ER - TY - JOUR AU - Lee F AU - Torp-Pedersen S AU - Littrup PJ AU - McLeary RD AU - McHugh TA AU - Smid AP AU - Stella PJ AU - Borlaza GS TI - Hypoechoic lesions of the prostate: clinical relevance of tumor size, digital rectal examination and prostate-specific antigen JA - Radiology PY - 1989/// VL - 170 SP - 29 EP - 32 ER - TY - JOUR AU - Chodak GW TI - Screening for prostate cancer; role of ultrasonography JA - Urol Clin North Am PY - 1989/// VL - 16 SP - 657 EP - ER - TY - JOUR AU - Chodak GW AU - Schoenberg HW TI - Progress and problems in screening for carcinoma of the prostate JA - World J Surg PY - 1989/// VL - 13 SP - 60 EP - ER - TY - JOUR AU - McNeal JE AU - Redwine EA AU - Freiha FS AU - Stamey TA TI - Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread JA - Am J Surg Pathol PY - 1988/// VL - 12 SP - 897 EP - ER - TY - JOUR AU - Villers A AU - McNeal JE AU - Redwine E AU - Freiha FS AU - Stamey TA TI - The role of perineural space invasion in the local spread of prostate adenocarcinoma JA - J Urol PY - 1989/// VL - 142 SP - 763 EP - 768 ER - TY - JOUR AU - Babayan RK AU - White RD AU - Austen G Jr AU - Krane RJ AU - Feldman M AU - Olsson CA TI - Benefits and complications of staging pelvic lymph node dissection in prostatic adenocarcinoma JA - Prostate PY - 1980/// VL - 1 SP - 345 EP - 349 ER - TY - JOUR AU - Jewett HJ TI - The present status of radical prostatectomy for stages A and B prostatic cancer JA - Urol Clin North Am PY - 1975/// VL - 2 SP - 105 EP - ER - TY - JOUR AU - Paulson DE TI - Impact of current staging procedures in assessing disease extent of prostatic carcinoma JA - J Urol PY - 1979/// VL - 121 SP - 300 EP - ER - TY - JOUR AU - Ebert T AU - Schmitz-Drager BJ AU - Burrig KF AU - Miller S AU - Pauli N AU - Kahn T AU - Ackermann R TI - Accuracy of imaging modalities in staging the local extent of prostate cancer JA - Urol Clin North Am PY - 1991/// VL - 18 SP - 453 EP - 457 ER - TY - JOUR AU - Andriole GL AU - Kavoussi LR AU - Torrence RJ AU - Lepor H AU - Catalona WJ TI - Transrectal ultrasonography in the diagnosis and staging of carcinoma of the prostate JA - J Urol PY - 1988/// VL - 140 SP - 758 EP - 760 ER - TY - JOUR AU - Salo JO AU - Kivisaari L AU - Rannikko S AU - Lehtonen T TI - Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic cancer before radical retropubic prostatectomy JA - J Urol PY - 1987/// VL - 137 SP - 435 EP - 438 ER - TY - JOUR AU - Hernandez AD AU - Smith JA TI - Transrectal ultrasonography for the early detection and staging of prostate cancer JA - Urol Clin North Am PY - 1990/// VL - 17 SP - 745 EP - ER - TY - JOUR AU - Emory TH AU - Reinke DB AU - Hill AL AU - Lange PH TI - Use of CT to reduce understaging in prostate cancer: comparison with conventional staging techniques JA - Am J Roentgenol PY - 1983/// VL - 141 SP - 351 EP - 354 ER - TY - JOUR AU - Golimbu M AU - Morales P AU - Al-Askari S AU - Shulman Y TI - CAT scanning in staging of prostatic cancer JA - Urology PY - 1981/// VL - 18 SP - 305 EP - 308 ER - TY - JOUR AU - Biondetti PR AU - Lee JK AU - Ling D AU - Catalona WJ TI - Clinical stage B prostate carcinoma: staging with MR imaging JA - Radiology PY - 1987/// VL - 162 SP - 325 EP - 329 ER - TY - JOUR AU - Mukamel E AU - Hannah J AU - Barbaric Z AU - deKernion JB TI - The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: comparison with the clinical and histological staging JA - J Urol PY - 1986/// VL - 136 SP - 1231 EP - 1233 ER - TY - JOUR AU - Scardino PT AU - Shinohara K AU - Wheeler TM AU - Carter SS TI - Staging of prostatic cancer. Value of ultrasonography JA - Urol Clin North Am PY - 1989/// VL - 16 SP - 713 EP - 734 ER - TY - JOUR AU - Smith MJV TI - The lymphatics of the prostate JA - Invest Urol PY - 1966/// VL - 3 SP - 439 EP - ER - TY - JOUR AU - Sawczuk IS AU - deVere White R AU - Gold RP AU - Olsson CA TI - Sensitivity of computed tomography in the evaluation of pelvic lymph node metastases from carcinoma of the bladder and prostate JA - Urology PY - 1983/// VL - 21 SP - 81 EP - ER - TY - JOUR AU - Hricak H AU - Dooms GC AU - Jeffrey RB AU - Avallone A AU - Jacobs D AU - Benton WK AU - Narayan P AU - Tanagho EA TI - Prostatic carcinoma: Staging by clinical assessment, CT and MR imaging JA - Radiology PY - 1987/// VL - 162 SP - 331 EP - 336 ER - TY - JOUR AU - Wajsman Z AU - Gamarra M AU - Park JJ AU - Beckley S AU - Pontes JE TI - Transabdominal fine needle aspiration of retroperitoneal lymph nodes in staging of genitourinary tract cancer JA - J Urol PY - 1982/// VL - 128 SP - 1238 EP - 1240 ER - TY - JOUR AU - Winfield HN AU - Donovan JF AU - See WA AU - Loening SA AU - Williams RD TI - Urological laparoscopic surgery JA - J Urol PY - 1991/// VL - 146 SP - 941 EP - 948 ER - TY - JOUR AU - Cantrell BB AU - DeKlerk DP AU - Eggleston JC AU - Boitnott JK AU - Walsh PC TI - Pathological factors that influence prognosis in Stage A prostatic cancer: the influence of extent versus grade JA - J Urol PY - 1981/// VL - 125 SP - 516 EP - 520 ER - TY - JOUR AU - Sheldon CA AU - Williams RD AU - Fraley EE TI - Incidental carcinoma of the prostate: A review of the literature and critical reappraisal of classification JA - J Urol PY - 1980/// VL - 124 SP - 626 EP - ER - TY - JOUR AU - Epstein JI AU - Paul G AU - Eggleston JC AU - Walsh PC TI - Prognosis of untreated Stage A1 prostatic cancer: A study of 94 cases with extended follow-up JA - J Urol PY - 1986/// VL - 136 SP - 837 EP - ER - TY - JOUR AU - Zincke H AU - Blute ML AU - Fallen MJ AU - Farrow GM TI - Radical prostatectomy for stage A adenocarcinoma of the prostate: Staging errors and their implications for treatment recommendations and disease outcome JA - J Urol PY - 1991/// VL - 146 SP - 1053 EP - 1058 ER - TY - JOUR AU - Smith JA AU - Cho YH TI - Management of stage A prostate cancer JA - Urol Clin North Am PY - 1990/// VL - 17 SP - 769 EP - ER - TY - JOUR AU - Catalona WJ AU - Bigg SW TI - Nerve-sparing radical prostatectomy: Evaluation of results after 250 patients JA - J Urol PY - 1990/// VL - 143 SP - 538 EP - ER - TY - JOUR AU - Smith PH TI - The case for no initial treatment of localized prostate cancer JA - Urol Clin North Am PY - 1990/// VL - 17 SP - 827 EP - ER - TY - JOUR AU - Mostofi FK TI - Grading of prostatic carcinoma JA - Cancer Chemother Reports PY - 1975/// VL - 59 SP - 111 EP - ER - TY - JOUR AU - Epstein JI AU - Berry SJ AU - Eggleston JC TI - Nuclear roundness factor: a predictor of progression in untreated Stage A2 prostate cancer JA - Cancer PY - 1984/// VL - 54 SP - 1666 EP - ER - TY - JOUR AU - Gleason DF TI - Classification of prostatic carcinomas JA - Cancer Chemother Reports PY - 1966/// VL - 50 SP - 125 EP - ER - TY - JOUR AU - Bagshaw MA AU - Cox RS AU - Ramback JE TI - Radiation therapy for localized prostate cancer JA - Urol Clin North Am PY - 1990/// VL - 17 SP - 787 EP - ER - TY - JOUR AU - Tribukait B AU - Ronstrum L AU - Esposti PL TI - Quantitative and qualitative aspects of flow DNA measurements related to the cytologic grade in prostatic carcinoma JA - Anat Quant Cytol PY - 1983/// VL - 5 SP - 107 EP - ER - TY - JOUR AU - DeVere White R AU - Deitch AD AU - Tomeshevsky P AU - Olsson CA TI - Flow cytometry in prostatic adenocarcinoma JA - World J Urol PY - 1983/// VL - 1 SP - 55 EP - ER - TY - JOUR AU - Stephenson RA AU - James BC AU - Gay H AU - Fair WR AU - Whitmore WF Jr AU - Melamed MR TI - Flow cytometry of prostate cancer: relationship of DNA content to survival JA - Cancer Res PY - 1987/// VL - 47 SP - 2504 EP - 2507 ER - TY - JOUR AU - Winkler HZ AU - Rainwater LM AU - Myers RP AU - Farrow GM AU - Therneau TM AU - Zincke H AU - Lieber MM TI - Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry JA - Mayo Clin Proc PY - 1988/// VL - 63 SP - 103 EP - 112 ER - TY - JOUR AU - Lee SE AU - Currin SM AU - Paulson DF AU - Walther PJ TI - Flow cytometric determination of ploidy in prostatic adenocarcinoma: A comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence JA - J Urol PY - 1988/// VL - 140 SP - 769 EP - ER - TY - JOUR AU - Ring KS AU - Karp FS AU - Olsson CA AU - O'Toole K AU - Bixon R AU - Benson MC TI - Flow cytometric analysis of adenocarcinoma of the prostate: the use of archival DNA analysis in conjunction with pathological grading to predict clinical outcome following radical retropubic prostatectomy JA - Prostate PY - 1990/// VL - 17 SP - 155 EP - 164 ER - TY - JOUR AU - Fregevu O AU - Pontes JE AU - Levin HS AU - Bauer TW AU - Tubbs RR TI - DNA ploidy of adenocarcinoma of the prostate obtained from freshly processed specimens JA - J Urol PY - 1991/// VL - 145 SP - 252A EP - ER - TY - JOUR AU - Whitmore WF AU - Hilaris B AU - Grabstald H TI - Retropubic implantation of iodine 125 in the treatment of prostate cancer JA - J Urol PY - 1972/// VL - 108 SP - 918 EP - ER - TY - JOUR AU - Paulson DF TI - Radical surgery vs radiotherapy for stage A2 and stage B (T1-2 NoMo) adenocarcinoma of the prostate JA - J Urol PY - 1982/// VL - 128 SP - 502 EP - ER - TY - JOUR AU - Bagshaw MA AU - Cox RS AU - Ray GR TI - Status of radiation treatment of prostate cancer at Stanford University JA - NCI Monogr PY - 1988/// VL - 7 SP - 47 EP - ER - TY - JOUR AU - Jewett HJ TI - Significance of the palpable prostatic nodule JA - JAMA PY - 1956/// VL - 160 SP - 838 EP - ER - TY - JOUR AU - Culp OS TI - Radical prostatectomy: Its past, present and possible future JA - J Urol PY - 1968/// VL - 98 SP - 618 EP - ER - TY - JOUR AU - McGowan DG TI - Radiation therapy in the management of localized carcinoma of the prostate JA - Cancer PY - 1977/// VL - 39 SP - 98 EP - ER - TY - JOUR AU - Pilepich MV TI - Radiation Therapy Oncology Group studies in carcinoma of the prostate JA - NCI Monogr PY - 1988/// VL - 7 SP - 61 EP - ER - TY - GEN AU - Bagshaw MA TI - Radiation therapy for cancer of the prostate JA - Diagnosis and Management of Genitourinary Cancer PY - 1988/// VL - SP - 425 EP - 445 ER - TY - JOUR AU - Walsh PC AU - Lepor H AU - Eggleston JC TI - Radical prostatectomy with preservation of sexual function: Anatomic and pathologic considerations JA - Prostate PY - 1983/// VL - 4 SP - 473 EP - ER - TY - JOUR AU - Peters CA AU - Walsh PC TI - Blood transfusion and anesthetic practices in radical retropubic prostatectomy JA - J Urol PY - 1985/// VL - 134 SP - 81 EP - ER - TY - JOUR AU - Catalona WJ TI - Patient selection for, results of and impact on tumor resection of potency-sparing radical prostatectomy JA - Urol Clin North Am PY - 1990/// VL - 17 SP - 819 EP - ER - TY - JOUR AU - Schellhammer PF AU - el-Mahdi AM AU - Higgins EM AU - Schultheiss TE AU - Ladaga LE AU - Babb TJ TI - Prostate biopsy after definitive treatment by interstitial 125 iodine implant or external beam radiation therapy JA - J Urol PY - 1987/// VL - 137 SP - 897 EP - 901 ER - TY - JOUR AU - Kabalin JN AU - Hodge KK AU - McNeal JE AU - Freiha FS AU - Stamey TA TI - Identification of residual cancer in the prostate following radiation therapy: Role of transrectal ultrasound guided biopsy and prostate specific antigen JA - J Urol PY - 1989/// VL - 142 SP - 326 EP - 331 ER - TY - JOUR AU - Scardino PT TI - The significance of biopsies after radiotherapy for prostatic cancer JA - Semin Urol PY - 1983/// VL - 1 SP - 243 EP - ER - TY - JOUR AU - Freiha FS AU - Bagshaw MA TI - Carcinoma of the prostate: results of post-irradiation biopsy JA - Prostate PY - 1984/// VL - 5 SP - 19 EP - M3 - 10.1002/pros.2990050103 N1 - 10.1002/pros.2990050103 UR - http://dx.doi.org/10.1002/pros.2990050103 ER - TY - JOUR AU - Ragde H AU - Blasko JC AU - Schumacher BS AU - Grimm PD AU - Cunningham DL AU - Sylvester J AU - Mate TP TI - Use of transrectal ultrasound in transperineal 125 iodine seeding for prostate cancer; methodology JA - J Endourol PY - 1989/// VL - 3 SP - 209 EP - ER - TY - JOUR AU - Donnelly BJ AU - Pedersen JE AU - Porter AT AU - McPhee MS TI - Iridium 192 brachytherapy in the treatment of cancer of the prostate JA - Urol Clin North Am PY - 1991/// VL - 18 SP - 481 EP - ER - TY - JOUR AU - Walsh PC AU - Jewett HJ TI - Radical surgery for prostate cancer JA - Cancer PY - 1980/// VL - 45 SP - 1906 EP - ER - TY - JOUR AU - Gibbons RP AU - Correa RJ Jr AU - Brannen GE AU - Weissman RM TI - Total prostatectomy for clinically localized prostatic cancer: long-term results JA - J Urol PY - 1989/// VL - 141 SP - 564 EP - 566 ER - TY - JOUR AU - Russell KJ AU - Dunatov C AU - Haferman MD AU - Griffeth JT AU - Polissar L AU - Pelton J AU - Cole SB AU - Taylor EW AU - Weins LW AU - Koh WJ TI - Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with radiation therapy JA - J Urol PY - 1991/// VL - 146 SP - 1046 EP - 1052 ER - TY - GEN AU - Pistenma DA AU - Bagshaw MA AU - Freiha FS TI - Extended field radiation therapy for prostatic adenocarcinoma: Status report of a limited prospective trial JA - Cancer of the Genitourinary Tract PY - 1979/// VL - SP - 229 EP - ER - TY - GEN AU - Bagshaw MA TI - Perspectives in the radiation treatment of prostatic cancer: History and current focus JA - Prostatic Cancer PY - 1979/// VL - SP - EP - ER - TY - JOUR AU - Zincke H AU - Fleming TR AU - Furlow WL AU - Myers RP AU - Utz DC TI - Radical retropubic prostatectomy and pelvic lymphadenopathy for high-stage cancer of the prostate JA - Cancer PY - 1981/// VL - 47 SP - 1901 EP - 1910 ER - TY - JOUR AU - Zinche H AU - Utz DC AU - Taylor WF TI - Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: Role of adjuvant treatment for residual cancer and in disease progression JA - J Urol PY - 1986/// VL - 135 SP - 1199 EP - ER - TY - JOUR AU - DeKernion JB AU - Neuwirth H AU - Stein A AU - Dorey F AU - Stenzl A AU - Hannah J AU - Blyth B TI - Prognosis of patients with stage D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy JA - J Urol PY - 1990/// VL - 144 SP - 700 EP - 703 ER - TY - JOUR AU - Fallon B AU - Williams RD TI - Current options in the management of clinical stage C prostatic carcinoma JA - Urol Clin North Am PY - 1990/// VL - 17 SP - 853 EP - ER - TY - JOUR AU - Austenfed MS AU - Davis BE TI - New concepts in the treatment of stage D1 adenocarcinoma of the prostate JA - Urol Clin N Am PY - 1990/// VL - 17 SP - 867 EP - ER - TY - JOUR AU - Walsh PC TI - Physiologic basis for hormonal therapy in carcinoma of the prostate JA - Urol Clin North Am PY - 1975/// VL - 2 SP - 125 EP - ER - TY - JOUR TI - Carcinoma of the prostate: Treatment comparisons JA - J Urol PY - 1967/// VL - 98 SP - 516 EP - ER - TY - JOUR AU - Byar DP AU - Corle DK TI - Hormone therapy for prostate cancer: results of the VACURG studies JA - NCI Monogr PY - 1988/// VL - 7 SP - 165 EP - ER - TY - JOUR AU - Shearer RJ AU - Hendry WF AU - Sommerville IF AU - Fergusson JD TI - Plasma testosterone: An accurate monitor of hormonal treatment in prostatic cancer JA - Br J Urol PY - 1973/// VL - 45 SP - 668 EP - ER - TY - JOUR TI - Leuprolide vs. diethylstilbestrol for metastatic prostate cancer JA - N Engl J Med PY - 1984/// VL - 311 SP - 1281 EP - ER - TY - JOUR AU - Kuhn JM AU - Billebaud T AU - Navratil H AU - Moulonguet A AU - Fiet J AU - Grise P AU - Louis JF AU - Costa P AU - Husson JM AU - Dahan R TI - Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen JA - N Engl J Med PY - 1989/// VL - 321 SP - 413 EP - 418 ER - TY - JOUR AU - Labrie F AU - Dupont A AU - Belanger A AU - Cusan L AU - Lacourciere Y AU - Monfette G AU - Laberge JG AU - Emond JP AU - Fazekas AT AU - Raynaud JP AU - Husson JM TI - New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen JA - Clin Invest Med PY - 1982/// VL - 5 SP - 267 EP - 275 ER - TY - JOUR AU - Crawford ED AU - Eisenberger MA AU - McLeod DG AU - Spaulding JT AU - Benson R AU - Dorr FA AU - Blumenstein BA AU - Davis MA AU - Goodman PJ TI - A controlled trial of leuprolide with and without flutamide in prostatic carcinoma JA - N Engl J Med PY - 1989/// VL - 321 SP - 419 EP - 424 ER - TY - JOUR AU - Trachtenberg J AU - Beland G AU - Elhilali MM AU - Fradet Y AU - Laroche B AU - Ramsey EW AU - Venner PN TI - A randomized trial of total androgen ablation vs orchiectomy in patients with metastatic prostate cancer JA - J Urol PY - 1989/// VL - 141 SP - 347A EP - ER - TY - JOUR AU - DeVoogt HJ AU - Klijn JG AU - Studer U AU - Schroeder FG AU - Sylvester R AU - de Pauw M TI - The combination of LHRH against buserilin with cyproterone acetate for 2 weeks initially vs continuously vs orchiectomy in the treatment of advanced prostate cancer. Results of EORTC trial 30843 JA - J Urol PY - 1991/// VL - 145 SP - 290A EP - ER - TY - JOUR AU - Gillat DA AU - Chadwick D AU - Gingell JC AU - O'Boyle P AU - Fellows G AU - Peeling B TI - A randomized control trial of the LHRH analogue zoladex vs cyproterone acetate vs a combination of the two JA - J Urol PY - 1991/// VL - 145 SP - 292A EP - ER - TY - JOUR AU - Janknegt RA AU - del Moral PF AU - Abbou C AU - Bracken B AU - Bartioletti R AU - Bernstein-Hann L AU - Brisset JM AU - Calais de Silva F AU - Chisholm G AU - Crawford E AU - Frick J AU - Goedhals L AU - Knonagel H AU - Venne P AU - Debruyne FMJ TI - Efficiency and tolerance of a total androgen blockade with anandron and orchiectomy: a double blind placebo controlled multicenter study JA - J Urol PY - 1991/// VL - 145 SP - 425A EP - ER - TY - JOUR AU - Eisenberger MA AU - Abrams JS TI - Chemotherapy for prostatic carcinoma JA - Semin Urol PY - 1988/// VL - 6 SP - 303 EP - ER - TY - JOUR AU - Linehan WM AU - Cooper M AU - LaRocca R AU - Walther GH AU - Weiss C AU - Stein C AU - Steinberg SM AU - Cassidy J AU - Uhrich M AU - Myers CM TI - Suramin therapy of patients with advanced hormone refractory prostate carcinoma JA - J Urol PY - 1991/// VL - 145 SP - 317A EP - ER - TY - JOUR AU - Crawford ED AU - Schutz M AU - Clejan S AU - Drago J AU - Resnick MI AU - Chodak GW AU - Gomella LG AU - Austenfeld M AU - Stone NN AU - Miles BJ TI - The effect of digital rectal examination on prostate specific antigen JA - J Urol PY - 1991/// VL - 145 SP - 398A EP - ER - TY - GEN AU - Parlow AL TI - Advanced cancer of the prostate: a consideration of radical prostatectomy in selected cases JA - NY State J Med PY - 1945/// VL - SP - 383 EP - 387 ER - TY - JOUR AU - Krain LS TI - Some epidemiologic variables in prostatic carcinoma in California JA - Prev Med PY - 1974/// VL - 3 SP - 154 EP - 159 ER - TY - JOUR AU - Ross RK AU - Deapen DM AU - Casagrande FT AU - Paganini-Hill A AU - Henderson BE TI - A cohort study of mortality from cancer of the prostate in Catholic priests JA - Br J Cancer PY - 1981/// VL - 43 SP - 233 EP - 255 ER -